IRIDEX - IRIX Company Value to Revenue Ratio

Public company logo of IRIDEX Corp. (IRIX)

The promotion of MicroPulse systems for retinal and glaucoma therapy is driving the growth of the mature business, which is reflected in the price action of IRIDEX Corporation (IRIX). The EV/Sales ratio demonstrates the current market valuation, while 366.77 captures a new level. Stability is ensured by the diversification of ophthalmological solutions, and the consumables sales model creates a sustainable cash flow.

IRIX IRIDEX: EV/Sales Multiple in the range 11/23/2025 - 11/20/2026

IRIX (iridex.com): analytical breakdowns and indicator data

- price and consensus price forecast:
Fundamental valuation:IRIDEX Corp IRIX
Mass-produced product of IRIDEX Corporation

To select assets with a high margin of safety, it is critical to evaluate business value without the influence of leverage. This EV/Sales valuation multiple compares the total enterprise value to revenue, allowing the investor to determine if there is an overpayment for the operating sales of IRIDEX Corporation (IRIX) amid the recovery of clinic capital expenditures on ophthalmological lasers in the US and Europe.

Competitor analysis for IRIDEX Corporation

Enterprise Value-to-Revenue Multiple DexCom, Inc.|PEN: EV/Sales Multiple|Company Value to Revenue Ratio NOVT|HAE (Haemonetics Company) - EV/Sales Multiple|Inspire Sleep (INSP) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple PRCT|Company Value to Revenue CONMED Corporation CNMD|EV/Sales Multiple PLSE (pulsebiosciences.com)|EV/Sales Multiple InMode Ltd INMD|PMI: Company Value to Revenue|SRDX: Enterprise Value-to-Revenue Ratio|SENS (Senseonics Corp) - Company Value to Revenue|NeuroPace, Inc. - Business Value to Revenue|TCMD (Tactile Systems Technology, Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple SANUWAVE Health SNWV|EV/Sales Multiple OM|Electromed Inc (ELMD) - Enterprise Value-to-Sales Ratio|LENSAR Inc - Company Value to Revenue|EV/Sales Multiple AVITA Medical, Inc. RCEL|Profound Medical Corp - EV/Sales Multiple|Total Company Value-to-Revenue Ratio Baird Medical BDMD|EDAP TMS (EDAP) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume APYX (Bovie Medical)|Enterprise Value-to-Revenue Ratio icecure-medical.com|Company Value to Revenue Pulmonx Corporation (LUNG)|EV/Sales Multiple TELA|CTSO - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Sensus Healthcare, Inc. SRTS|ZYXI: Company Value to Revenue Ratio|ECOR: Company Value to Revenue|Vicarious Surgical Inc - Enterprise Value-to-Revenue Coefficient|IINN: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple SeaStar Medical (ICU)|Enterprise Value-to-Revenue Ratio Intelligent Bio Solutions Inc.|Enterprise Value-to-Revenue Multiple Beyond Air XAIR|Enterprise Value-to-Revenue Ratio Profusa Inc. (PFSA)|SSKN (STRATA Skin Sciences, Inc.) - Business Value to Revenue|EV/Sales Multiple GCTK (GlucoTrack Inc.)|NanoVibronix, Inc. (NAOV) - Enterprise Value-to-Revenue Multiple|VERO - Enterprise Value-to-Revenue Ratio|NUWE: Enterprise Value-to-Revenue Ratio|Aethlon Medical Inc (AEMD) - Enterprise Value-to-Revenue Ratio|TransEnterix (ASXC) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio Avinger|BSGM: Business Value to Revenue|EV/Sales Multiple CUTR|Total Company Value-to-Revenue Ratio Know Labs, Inc.|EV/Sales Multiple NARI (Inari Medical)|Business Value to Revenue NVRO|ReShape Lifesciences, Inc. - EV/Sales Multiple|Business Value to Revenue SILK (Silk Road Medical, Inc.)